Citation: Sg. Terra et Sm. Tsunoda, OPIOID ANTAGONISTS IN THE TREATMENT OF PRURITUS FROM CHOLESTATIC LIVER-DISEASE, The Annals of pharmacotherapy, 32(11), 1998, pp. 1228-1230
Citation: Sg. Terra et al., A REVIEW OF TISSUE-PLASMINOGEN ACTIVATOR IN THE TREATMENT OF VENOOCCLUSIVE LIVER-DISEASE AFTER BONE-MARROW TRANSPLANTATION, Pharmacotherapy, 17(5), 1997, pp. 929-937
Citation: Sm. Tsunoda et Ft. Aweeka, THE USE OF THERAPEUTIC DRUG-MONITORING TO OPTIMIZE IMMUNOSUPPRESSIVE THERAPY, Clinical pharmacokinetics, 30(2), 1996, pp. 107-140
Citation: Rz. Harris et Sm. Tsunoda, TIMING OF DRUG ADMINISTRATION TO PREVENT DRUG-INTERACTIONS, JAMA, the journal of the American Medical Association, 275(6), 1996, pp. 445-446
Authors:
HARRIS RZ
TSUNODA SM
MROCZKOWSKI P
WONG H
BENET LZ
Citation: Rz. Harris et al., THE EFFECTS OF MENOPAUSE AND HORMONE REPLACEMENT THERAPIES ON PREDNISOLONE AND ERYTHROMYCIN PHARMACOKINETICS, Clinical pharmacology and therapeutics, 59(4), 1996, pp. 429-435
Citation: Sm. Tsunoda et al., ORAL PROGESTERONE THERAPY DOES NOT AFFECT THE PHARMACOKINETICS OF PREDNISOLONE AND ERYTHROMYCIN IN POSTMENOPAUSAL WOMEN, Clinical pharmacology and therapeutics, 57(2), 1995, pp. 182-182
Authors:
MROCZKOWSKI PJ
HARRIS RZ
TSUNODA SM
BENET LZ
LANE N
Citation: Pj. Mroczkowski et al., HORMONE REPLACEMENT THERAPY DECREASES THE ACUTE EFFECTS OF PREDNISOLONE ON BONE-FORMATION IN POSTMENOPAUSAL WOMEN, Arthritis and rheumatism, 38(9), 1995, pp. 1436-1436